Shellers honored as National Liberty Museum’s “2017 Heroes of Liberty”
The National Liberty Museum honored Stephen and Sandra Sheller as “2017 Heroes of Liberty” at the 18th Annual Glass Auction & Gala held on October 7, 2017 at the Sheraton Philadelphia Downtown...
View ArticleLone Risperdal Defense Verdict for J&J Overturned
The only Risperdal verdict in favor of the defense, Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, was overturned by the Superior Court of Pennsylvania. The three judge panel...
View ArticleHHS Pick, Former Eli Lilly Exec, Grilled over Zyprexa Scandal
President Trump’s nomination of Alex Azar, a former top executive at Eli Lilly, to lead the Department of Health and Human Services (HHS) has come under scrutiny of Senator Elizabeth Warren (MA-D) and...
View ArticleSuperior Court Allows Punitive Damages in Risperdal Mass Torts
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous...
View ArticleSheller Joins Phila. in Suit Against Opioid Manufacturers
Sheller PC is one of five private law firms assisting the city of Philadelphia’s Law Department in its suit against pharmaceutical companies attempting to hold them accountable for the current opioid...
View ArticleClik here to view.
More Lawsuits Against Opioid Makers, Feds Assist Cities/States
More than 100 states, cities, counties and other public entities have filed opioid-related lawsuits against the drug manufacturers in 2017. The lawsuits being filed continue into 2018 including the...
View ArticleClik here to view.
Sheller Panelist on Penn Law’s Legal Response to Opioid Conference
Sheller PC’s founder, Stephen Sheller, joined other litigators, judges and state prosecutors at a conference to discuss the legal response to the opioid crisis. The forum was hosted by University of...
View ArticleState and Local Lawmakers Goals Conflict in Opioid Litigation
Plaintiffs’ in the multi-district litigation, which consisting of more than 2,500 cities and counties, suing opioid manufacturers and distributors for their role in the opioid crisis find they have...
View ArticlePlaintiff’s Counsel Vows to Have $8B Risperdal Verdict Reinstated
Philadelphia Court of Common Pleas Judge Kenneth Powell reduced an October 2019 $8 billion punitive damages verdict against J&J to $6.8 million. A jury had awarded the figure over allegations that...
View ArticlePharma Execs Admits to Deceptive Marketing of Opioids
In a rare admission to PBS Frontline & the Finical Times, a pharmaceutical executive acknowledged that he knowingly orchestrated an illegal scheme to boost sales of a powerful opiate painkiller...
View ArticleRisperdal Case Reinstated After Janssen Appeal Denied
The Pennsylvania Supreme Court declined to hear Janssen Pharmacuetical’s request for an appeal of a lower courts decision to reinstate the lawsuit of a Texas man who took Risperdal as a child. The...
View ArticleDOJ Blocks Criminal Charges Against Walmart in Opioid Crisis
A recent ProPublica investigative report calls into question the Trump Administration’s commitment to ending the opioid crisis, criminally charging those responsible, and ensuring that protections are...
View ArticleClik here to view.
$8 Billion Risperdal Verdict Tops Legal News in 2019
April 2020 Update: Stephen Sheller has been recognized by the American Association for Justice with AAJ’s 2019 Top Verdict Award. “Each year, American Association for Justice releases the Top Verdicts...
View ArticlePharmacies Face New Suit In Opioids Crisis
A new court filing against big American pharmacy retailers has been submitted in the multi-district litigation in Ohio Federal Court overseen by Judge Dan Polster. The complaint accuses major...
View ArticleAppeals Court Upholds Block of Drug Pricing Transparency
A DC Circuit court upheld a federal judge’s ruling striking down the Department of Health and Human Services’ new rule requiring drug companies to disclose the price of a 30 day supply in advertising....
View ArticlePA Supreme Court Upholds $70 Million Risperdal Verdict
The Pennsylvania Supreme Court has denied Johnson & Johnson’s request to overturn the $70 million Risperdal verdict upheld by a Superior court panel of judges last year. The case, A.Y. v. Janssen...
View ArticlePurdue Pleads Guilty to Felonies, Plea Deal Receives Criticism
Purdue Pharma pleads guilty to criminal charges for illegal marketing of the its highly addictive painkiller, OxyContin. Corporations often pay penalties and fines for wrongdoing, yet criminal charges...
View ArticleClik here to view.
Stephen Sheller Honored as The Legal’s 2020 Pennsylvania Trailblazer
2020 Pennsylvania Trailblazers brought to you by The Legal Intelligencer Watch: Deadly Drugs – Johnson & Johnson’s Risperdal
View ArticleHealth and Life Science Litigation in 2021
With the Biden administration taking the White House last month, the new administration has been vocal about enforcing antitrust and fraud laws, especially as it pertains to those who took advance of...
View ArticleCEOs Receive Massive Bonuses Despite Ethics Scandals, Pass Cost on to...
When executive compensation is tied solely to short term profits, and not balanced against company payouts for wrongdoing, there’s an increased incentive for executive fraud. Recently Wells Fargo bank...
View Article